IFNG and neoplasm: Therefore, it is difficult to envisage that the HLA-B18/NY-ESO-188–96 epitope would be ever presented in sufficient level directly on tumor cell surface unless there was a concomitant infection in the tumor-bearing host and the infection resulted in sufficient IFN-γ production to induce immunoproteasome in these cells.